Birdwatch Note
2024-05-02 05:05:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
この動画は21年末のもので https://twitter.com/fseiichizb4/status/1649802350574604288 試験がなかなかちゃんと行われない理由を説明しています(動画10秒 その後、動画があげた興和、北里のイベルメクチンの2つのランダム化比較試験(RCT)で有効性は見だされず https://www.kowa.co.jp/news/2022/press20220926.html https://www.kitasato-u.ac.jp/khp/topics/2022/20220930.html 世界的にもRCTのメタ解析でも臨床アウトカムの改善への有効性は見だされていません。 https://academic.oup.com/cid/article/74/6/1022/6310839?login=false https://journals.lww.com/aptm/Fulltext/2023/16010/Efficacy_and_safety_of_ivermectin_in_patients_with.2.aspx こうした経緯は有効性を見だしCOVID-19重症例への使用が承認された安価なデキサメタゾン↓等と対照的で https://dm-rg.net/news/2020/07/020449.html 臨床試験で有効性が見だせなかった薬は一般に承認されないという単純な事実に注意が必要です。
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1785888606936326501
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1785898264505757808
- noteId - 1785898264505757808
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1714626301301
- tweetId - 1785888606936326501
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- この動画は21年末のもので https://twitter.com/fseiichizb4/status/1649802350574604288 試験がなかなかちゃんと行われない理由を説明しています(動画10秒 その後、動画があげた興和、北里のイベルメクチンの2つのランダム化比較試験(RCT)で有効性は見だされず https://www.kowa.co.jp/news/2022/press20220926.html https://www.kitasato-u.ac.jp/khp/topics/2022/20220930.html 世界的にもRCTのメタ解析でも臨床アウトカムの改善への有効性は見だされていません。 https://academic.oup.com/cid/article/74/6/1022/6310839?login=false https://journals.lww.com/aptm/Fulltext/2023/16010/Efficacy_and_safety_of_ivermectin_in_patients_with.2.aspx こうした経緯は有効性を見だしCOVID-19重症例への使用が承認された安価なデキサメタゾン↓等と対照的で https://dm-rg.net/news/2020/07/020449.html 臨床試験で有効性が見だせなかった薬は一般に承認されないという単純な事実に注意が必要です。
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-05-02 05:05:01 UTC (1714626301301) |
2024-05-02 09:14:48 UTC (1714641288425) |
CURRENTLY_RATED_HELPFUL | 2024-05-03 08:41:02 UTC (1714725662862) |
CURRENTLY_RATED_HELPFUL | 2024-05-02 09:14:48 UTC (1714641288425) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-05-03 00:56:02 -0500 | Rating Details | |
2024-05-02 17:23:53 -0500 | Rating Details | |
2024-05-02 15:54:27 -0500 | Rating Details | |
2024-05-02 11:12:43 -0500 | Rating Details | |
2024-05-02 09:14:22 -0500 | Rating Details | |
2024-05-02 05:22:40 -0500 | Rating Details | |
2024-05-02 04:12:56 -0500 | Rating Details | |
2024-05-02 03:09:20 -0500 | Rating Details | |
2024-05-02 02:48:41 -0500 | Rating Details | |
2024-05-02 01:53:31 -0500 | Rating Details | |
2024-05-02 01:26:54 -0500 | Rating Details | |
2024-05-02 01:04:36 -0500 | Rating Details | |
2024-05-02 00:48:05 -0500 | Rating Details | |
2024-05-02 00:38:05 -0500 | Rating Details | |
2024-05-02 00:36:53 -0500 | Rating Details | |
2024-05-02 00:33:49 -0500 | Rating Details | |
2024-05-02 00:19:46 -0500 | Rating Details | |
2024-05-03 12:42:09 -0500 | Rating Details | |
2024-05-03 11:54:29 -0500 | Rating Details | |
2024-05-03 08:02:32 -0500 | Rating Details | |
2024-05-03 03:33:56 -0500 | Rating Details | |
2024-05-03 00:18:17 -0500 | Rating Details | |
2024-05-02 21:43:53 -0500 | Rating Details | |
2024-05-02 21:11:36 -0500 | Rating Details | |
2024-05-02 20:43:34 -0500 | Rating Details | |
2024-05-02 12:02:53 -0500 | Rating Details | |
2024-05-02 11:13:25 -0500 | Rating Details | |
2024-05-02 10:48:59 -0500 | Rating Details | |
2024-05-02 10:18:37 -0500 | Rating Details | |
2024-05-02 09:45:10 -0500 | Rating Details | |
2024-05-02 08:18:48 -0500 | Rating Details | |
2024-05-02 08:07:30 -0500 | Rating Details | |
2024-05-02 08:00:08 -0500 | Rating Details | |
2024-05-02 05:44:49 -0500 | Rating Details | |
2024-05-02 04:45:05 -0500 | Rating Details | |
2024-05-02 04:00:01 -0500 | Rating Details | |
2024-05-02 03:40:04 -0500 | Rating Details | |
2024-05-02 03:40:01 -0500 | Rating Details | |
2024-05-02 03:35:48 -0500 | Rating Details | |
2024-05-02 03:32:06 -0500 | Rating Details | |
2024-05-02 02:08:03 -0500 | Rating Details | |
2024-05-02 02:00:13 -0500 | Rating Details | |
2024-05-02 01:56:13 -0500 | Rating Details | |
2024-05-02 01:29:33 -0500 | Rating Details | |
2024-05-02 01:23:32 -0500 | Rating Details | |
2024-05-02 01:23:22 -0500 | Rating Details | |
2024-05-02 01:18:26 -0500 | Rating Details | |
2024-05-02 01:07:20 -0500 | Rating Details | |
2024-05-02 01:05:00 -0500 | Rating Details | |
2024-05-02 00:56:10 -0500 | Rating Details | |
2024-05-02 00:54:16 -0500 | Rating Details | |
2024-05-02 00:49:51 -0500 | Rating Details | |
2024-05-02 00:47:52 -0500 | Rating Details | |
2024-05-02 00:41:28 -0500 | Rating Details | |
2024-05-02 00:36:19 -0500 | Rating Details | |
2024-05-02 00:19:40 -0500 | Rating Details | |
2024-05-02 00:16:33 -0500 | Rating Details | |
2024-05-04 22:54:57 -0500 | Rating Details | |
2024-05-04 12:49:36 -0500 | Rating Details | |
2024-05-03 21:02:13 -0500 | Rating Details | |
2024-05-03 19:29:39 -0500 | Rating Details | |
2024-05-03 10:41:12 -0500 | Rating Details | |
2024-05-03 06:46:58 -0500 | Rating Details | |
2024-05-03 03:05:36 -0500 | Rating Details | |
2024-05-03 03:04:47 -0500 | Rating Details | |
2024-05-03 01:45:22 -0500 | Rating Details | |
2024-05-02 19:06:48 -0500 | Rating Details | |
2024-05-02 17:35:43 -0500 | Rating Details | |
2024-05-02 16:08:38 -0500 | Rating Details | |
2024-05-02 10:28:56 -0500 | Rating Details | |
2024-05-02 07:27:11 -0500 | Rating Details | |
2024-05-02 07:24:23 -0500 | Rating Details | |
2024-05-02 05:30:13 -0500 | Rating Details | |
2024-05-02 04:11:43 -0500 | Rating Details | |
2024-05-02 04:07:33 -0500 | Rating Details | |
2024-05-02 03:37:17 -0500 | Rating Details | |
2024-05-02 03:23:21 -0500 | Rating Details | |
2024-05-02 03:14:11 -0500 | Rating Details | |
2024-05-02 02:22:08 -0500 | Rating Details | |
2024-05-02 02:16:03 -0500 | Rating Details | |
2024-05-02 01:44:10 -0500 | Rating Details | |
2024-05-02 01:24:03 -0500 | Rating Details | |
2024-05-02 01:19:26 -0500 | Rating Details | |
2024-05-02 01:17:33 -0500 | Rating Details | |
2024-05-02 01:10:26 -0500 | Rating Details | |
2024-05-02 01:04:26 -0500 | Rating Details | |
2024-05-02 00:52:10 -0500 | Rating Details | |
2024-05-02 00:43:36 -0500 | Rating Details | |
2024-05-02 00:42:31 -0500 | Rating Details | |
2024-05-02 00:40:18 -0500 | Rating Details | |
2024-05-02 00:39:47 -0500 | Rating Details | |
2024-05-02 00:35:07 -0500 | Rating Details | |
2024-05-02 00:34:43 -0500 | Rating Details | |
2024-05-02 00:30:04 -0500 | Rating Details | |
2024-05-05 12:12:35 -0500 | Rating Details | |
2024-05-05 07:43:45 -0500 | Rating Details | |
2024-05-06 05:19:13 -0500 | Rating Details | |
2024-05-05 06:46:05 -0500 | Rating Details | |
2024-05-06 04:50:28 -0500 | Rating Details | |
2024-05-06 03:43:46 -0500 | Rating Details | |
2024-05-05 00:45:25 -0500 | Rating Details | |
2024-05-05 00:16:26 -0500 | Rating Details | |
2024-05-04 18:32:32 -0500 | Rating Details | |
2024-05-04 09:44:59 -0500 | Rating Details | |
2024-05-03 12:43:58 -0500 | Rating Details | |
2024-05-03 10:19:03 -0500 | Rating Details | |
2024-05-03 10:00:44 -0500 | Rating Details | |
2024-05-03 07:47:47 -0500 | Rating Details | |
2024-05-03 05:24:20 -0500 | Rating Details | |
2024-05-03 03:48:49 -0500 | Rating Details | |
2024-05-03 02:49:38 -0500 | Rating Details | |
2024-05-05 02:22:18 -0500 | Rating Details | |
2024-05-03 17:33:07 -0500 | Rating Details | |
2024-05-03 10:14:06 -0500 | Rating Details | |
2024-05-03 09:16:53 -0500 | Rating Details | |
2024-05-03 09:16:22 -0500 | Rating Details | |
2024-05-03 07:22:58 -0500 | Rating Details | |
2024-05-03 05:40:22 -0500 | Rating Details | |
2024-05-03 04:10:04 -0500 | Rating Details | |
2024-05-03 01:01:44 -0500 | Rating Details | |
2024-05-02 17:41:22 -0500 | Rating Details | |
2024-05-02 11:07:57 -0500 | Rating Details | |
2024-05-02 09:54:01 -0500 | Rating Details | |
2024-05-02 08:00:16 -0500 | Rating Details | |
2024-05-02 06:07:58 -0500 | Rating Details | |
2024-05-02 04:06:14 -0500 | Rating Details | |
2024-05-02 03:00:06 -0500 | Rating Details | |
2024-05-02 02:34:03 -0500 | Rating Details | |
2024-05-02 01:58:15 -0500 | Rating Details | |
2024-05-02 01:41:56 -0500 | Rating Details | |
2024-05-02 01:41:42 -0500 | Rating Details | |
2024-05-02 01:35:34 -0500 | Rating Details | |
2024-05-02 01:35:29 -0500 | Rating Details | |
2024-05-02 01:31:25 -0500 | Rating Details | |
2024-05-02 00:56:22 -0500 | Rating Details | |
2024-05-02 00:48:53 -0500 | Rating Details | |
2024-05-02 00:44:40 -0500 | Rating Details | |
2024-05-02 00:37:27 -0500 | Rating Details | |
2024-05-02 00:35:20 -0500 | Rating Details | |
2024-05-02 00:34:16 -0500 | Rating Details | |
2024-05-02 00:32:02 -0500 | Rating Details | |
2024-05-02 00:23:36 -0500 | Rating Details | |
2024-05-02 00:18:25 -0500 | Rating Details | |
2024-05-02 10:10:02 -0500 | Rating Details | |
2024-05-02 22:07:22 -0500 | Rating Details | |
2024-05-02 20:18:30 -0500 | Rating Details | |
2024-05-02 05:59:00 -0500 | Rating Details | |
2024-05-02 03:54:51 -0500 | Rating Details | |
2024-05-02 02:58:40 -0500 | Rating Details | |
2024-05-02 00:39:18 -0500 | Rating Details | |
2024-05-02 21:34:56 -0500 | Rating Details | |
2024-05-03 02:12:04 -0500 | Rating Details | |
2024-05-03 01:46:09 -0500 | Rating Details | |
2024-05-02 22:04:52 -0500 | Rating Details | |
2024-05-02 08:26:24 -0500 | Rating Details | |
2024-05-02 05:52:39 -0500 | Rating Details | |
2024-05-02 00:45:54 -0500 | Rating Details | |
2024-05-02 00:22:24 -0500 | Rating Details | |
2024-05-02 00:15:16 -0500 | Rating Details | |
2024-05-03 08:50:51 -0500 | Rating Details |